Cantor Fitzgerald Reiterates Overweight on Merck & Co, Maintains $135 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Merck & Co (NYSE:MRK) and maintained a $135 price target.
March 27, 2024 | 1:44 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cantor Fitzgerald maintains an Overweight rating on Merck & Co with a $135 price target.
The reiteration of an Overweight rating and the maintenance of a $135 price target by a reputable analyst like Louise Chen from Cantor Fitzgerald could instill confidence among investors and potentially drive the stock price up in the short term. The specific mention of the price target provides a clear benchmark for expectations.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100